Nucleic acid-polypeptide compositions and methods of inducing exon skipping
US11311627B1 · kind B1 · utility
21Cited by
78References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2021 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Aug 31, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.